BitFrontier Capital Holdings Transitions to EVERMIND Holdings with a Focus on Human Optimization and Longevity

BitFrontier Capital Holdings, Inc. (OTC: BFCH), now transitioning to EVERMIND Holdings, Inc., has announced a strategic pivot towards human optimization, cognitive performance, and longevity infrastructure. This shift is spearheaded by Dr. Jordan P. Balencic, the new CEO and controlling shareholder, who has already initiated significant financial restructuring. The company has retired over $2 million in legacy convertible debt and reduced total liabilities to under $94,000, marking a crucial step towards financial stability and investor confidence.

The newly unveiled business plan introduces a fixed-price equity conversion at $0.01 per share, aiming to eliminate variable-rate dilution from legacy obligations. This move is designed to lay a transparent foundation for the company's future growth. EVERMIND Holdings is structured into three divisions: EVERMIND Labs, EVERMIND Technologies, and EVERMIND Manufacturing. Each division focuses on scalable opportunities in wellness brands, brain performance technology, and domestic co-manufacturing infrastructure, respectively, to drive revenue and innovation.

To achieve its ambitious objectives, EVERMIND Holdings is preparing a $150,000 seed round. This funding will support rebranding efforts, regulatory filings, and the development of corporate communications strategies. The company is also considering a potential Regulation A offering in 2025, depending on share price and regulatory qualifications. While no definitive acquisition agreements are in place, preliminary discussions regarding potential transactions are underway.

Investors and stakeholders can find more details about the business plan on the company's website at https://evermindholdings.com. This strategic overhaul under Dr. Balencic's leadership signifies EVERMIND Holdings' commitment to becoming a frontrunner in the human optimization and longevity sectors.